Incyte Corp.

NASDAQ:INCY   12:44:20 PM EDT
76.43
-0.08 (-0.10%)
Other Pre-Announcement

Incyte Reports 2022 First Quarter Results

Published: 05/03/2022 11:45 GMT
Incyte Corp. (INCY) - Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs.
Raising Bottom End of Full Year Guidance to New Range of $2.33 to $2.40 Billion.
Qtrly Total Product and Royalty Revenues of $728 Million (+20% Y/y).
Qtrly GAAP Diluted EPS $0.17.
Qtrly Non-GAAP Diluted EPS $0.55.
Q1 Earnings per Share View $0.67, Revenue View $750.0 Million -- Refinitiv Ibes Data (analyst estimates).